Glesatinib

Scientific Overview: Multi-targeted MET/RON/VEGFR2 inhibitor. MET + RON + angiogenesis

Mechanism of Action: MET/RON/VEGFR2 Inhibitor

Purity: ≥99%  |  Molecular Formula: N/A

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.